Bharat Book added a new report on " Pharmaceuticals report, “Transition Therapeutics Inc. - Product Pipeline Review - Q1 2011” provides data on the Transition Therapeutics Inc.’s research and development focus." Transition Therapeutics Inc. - Product Pipeline Review - Q1 2011 The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Transition Therapeutics Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Transition Therapeutics Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. http://www.bharatbook.com/detail.asp?id=158565&rt=Transition-Therapeutics-Inc-Product-Pipeline-Review-Q1-2011.html - Transition Therapeutics Inc. - Brief Transition Therapeutics Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Transition Therapeutics Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Transition Therapeutics Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Transition Therapeutics Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Transition Therapeutics Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Transition Therapeutics Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Transition Therapeutics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Transition Therapeutics Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Transition Therapeutics Inc. and identify potential opportunities in those areas. For more information kindly visit : http://www.bharatbook.com/detail.asp?id=158565&rt=Transition-Therapeutics-Inc-Product-Pipeline-Review-Q1-2011.html Related Reports Global Protein Therapeutics Market Analysis Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/BharatBook
Related Articles -
Transition Therapeutics Inc, Demand Forecast, Market, Market Forecast, Market Growth, Market Leaders.Research,
|